127 related articles for article (PubMed ID: 17603222)
1. Influence of formulation viscosity on drug absorption following nasal application in rats.
Furubayashi T; Inoue D; Kamaguchi A; Higashi Y; Sakane T
Drug Metab Pharmacokinet; 2007 Jun; 22(3):206-11. PubMed ID: 17603222
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of the contribution of the nasal cavity and gastrointestinal tract to drug absorption following nasal application to rats.
Furubayashi T; Kamaguchi A; Kawaharada K; Masaoka Y; Kataoka M; Yamashita S; Higashi Y; Sakane T
Biol Pharm Bull; 2007 Mar; 30(3):608-11. PubMed ID: 17329868
[TBL] [Abstract][Full Text] [Related]
3. Effect of poly-L-arginine on the nasal absorption of FITC-dextran of different molecular weights and recombinant human granulocyte colony-stimulating factor (rhG-CSF) in rats.
Miyamoto M; Natsume H; Satoh I; Ohtake K; Yamaguchi M; Kobayashi D; Sugibayashi K; Morimoto Y
Int J Pharm; 2001 Sep; 226(1-2):127-38. PubMed ID: 11532576
[TBL] [Abstract][Full Text] [Related]
4. The enhancing effect of nasal absorption of FITC-dextran 4,400 by beta-sitosterol beta-D-glucoside in rabbits.
Nakamura K; Maitani Y; Takayama K
J Control Release; 2002 Feb; 79(1-3):147-55. PubMed ID: 11853926
[TBL] [Abstract][Full Text] [Related]
5. N-sulfonato-N,O-carboxymethylchitosan: a novel polymeric absorption enhancer for the oral delivery of macromolecules.
Thanou M; Henderson S; Kydonieus A; Elson C
J Control Release; 2007 Feb; 117(2):171-8. PubMed ID: 17184870
[TBL] [Abstract][Full Text] [Related]
6. Chitosan citrate as multifunctional polymer for vaginal delivery. Evaluation of penetration enhancement and peptidase inhibition properties.
Bonferoni MC; Sandri G; Rossi S; Ferrari F; Gibin S; Caramella C
Eur J Pharm Sci; 2008 Feb; 33(2):166-76. PubMed ID: 18248966
[TBL] [Abstract][Full Text] [Related]
7. Confocal laser scanning microscopic visualization of the transport of dextrans after nasal administration to rats: effects of absorption enhancers.
Marttin E; Verhoef JC; Cullander C; Romeijn SG; Nagelkerke JF; Merkus FW
Pharm Res; 1997 May; 14(5):631-7. PubMed ID: 9165535
[TBL] [Abstract][Full Text] [Related]
8. Analysis of transient and reversible effects of poly-L-arginine on the in vivo nasal absorption of FITC-dextran in rats.
Ohtake K; Natsume H; Ueda H; Morimoto Y
J Control Release; 2002 Aug; 82(2-3):263-75. PubMed ID: 12175742
[TBL] [Abstract][Full Text] [Related]
9. Screening of cationic compounds as an absorption enhancer for nasal drug delivery.
Natsume H; Iwata S; Ohtake K; Miyamoto M; Yamaguchi M; Hosoya K; Kobayashi D; Sugibayashi K; Morimoto Y
Int J Pharm; 1999 Aug; 185(1):1-12. PubMed ID: 10425360
[TBL] [Abstract][Full Text] [Related]
10. Effects of polyamidoamine (PAMAM) dendrimers on the nasal absorption of poorly absorbable drugs in rats.
Dong Z; Katsumi H; Sakane T; Yamamoto A
Int J Pharm; 2010 Jun; 393(1-2):244-52. PubMed ID: 20417700
[TBL] [Abstract][Full Text] [Related]
11. Direct drug transport from the rat nasal cavity to the cerebrospinal fluid: the relation to the molecular weight of drugs.
Sakane T; Akizuki M; Taki Y; Yamashita S; Sezaki H; Nadai T
J Pharm Pharmacol; 1995 May; 47(5):379-81. PubMed ID: 7494186
[TBL] [Abstract][Full Text] [Related]
12. Aminated gelatin as a nasal absorption enhancer for peptide drugs: evaluation of absorption enhancing effect and nasal mucosa perturbation in rats.
Wang J; Sakai S; Deguchi Y; Bi D; Tabata Y; Morimoto K
J Pharm Pharmacol; 2002 Feb; 54(2):181-8. PubMed ID: 11848281
[TBL] [Abstract][Full Text] [Related]
13. Insoluble powder formulation as an effective nasal drug delivery system.
Ishikawa F; Murano M; Hiraishi M; Yamaguchi T; Tamai I; Tsuji A
Pharm Res; 2002 Aug; 19(8):1097-104. PubMed ID: 12240934
[TBL] [Abstract][Full Text] [Related]
14. Nasal Absorption of Macromolecules from Powder Formulations and Effects of Sodium Carboxymethyl Cellulose on Their Absorption.
Tanaka A; Furubayashi T; Matsushita A; Inoue D; Kimura S; Katsumi H; Sakane T; Yamamoto A
PLoS One; 2016; 11(9):e0159150. PubMed ID: 27598527
[TBL] [Abstract][Full Text] [Related]
15. Sodium hyaluronate as a mucoadhesive component in nasal formulation enhances delivery of molecules to brain tissue.
Horvát S; Fehér A; Wolburg H; Sipos P; Veszelka S; Tóth A; Kis L; Kurunczi A; Balogh G; Kürti L; Eros I; Szabó-Révész P; Deli MA
Eur J Pharm Biopharm; 2009 May; 72(1):252-9. PubMed ID: 19007885
[TBL] [Abstract][Full Text] [Related]
16. Chitosan ascorbate: a chitosan salt with improved penetration enhancement properties.
Rossi S; Marciello M; Sandri G; Bonferoni MC; Ferrari F; Caramella C
Pharm Dev Technol; 2008; 13(6):513-21. PubMed ID: 18720244
[TBL] [Abstract][Full Text] [Related]
17. Improved nasal absorption of drugs using poly-L-arginine: effects of concentration and molecular weight of poly-L-arginine on the nasal absorption of fluorescein isothiocyanate-dextran in rats.
Miyamoto M; Natsume H; Iwata S; Ohtake K; Yamaguchi M; Kobayashi D; Sugibayashi K; Yamashina M; Morimoto Y
Eur J Pharm Biopharm; 2001 Jul; 52(1):21-30. PubMed ID: 11438420
[TBL] [Abstract][Full Text] [Related]
18. Molecular weight dependence on bioavailability of FITC-dextran after administration of self-dissolving micropile to rat skin.
Ito Y; Ise A; Sugioka N; Takada K
Drug Dev Ind Pharm; 2010 Jul; 36(7):845-51. PubMed ID: 20180657
[TBL] [Abstract][Full Text] [Related]
19. Enhancement of nasal absorption of large molecular weight compounds by combination of mucolytic agent and nonionic surfactant.
Matsuyama T; Morita T; Horikiri Y; Yamahara H; Yoshino H
J Control Release; 2006 Jan; 110(2):347-352. PubMed ID: 16274829
[TBL] [Abstract][Full Text] [Related]
20. Effect of sodium taurodihydrofusidate on nasal drug delivery: differences in its concentration and penetrant molecular weight.
Hosoya K; Kubo H; Akutsu T; Natsume H; Sugibayashi K; Morimoto Y
Arch Pharm Res; 1994 Apr; 17(2):57-9. PubMed ID: 10319131
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
